The Fall Melanoma Symposium is being rescheduled.
We are excited to be offering this semi-annual event as a webinar for the first time! Date will be announced soon. For the most up-to-date information, please sign up to receive our eNewsletter.
Melanoma Symposium: Treatment Updates & BRAF Mutations
Dr. Ryan Sullivan
Dr. Ryan Sullivan is board certified in Medical Oncology and an Attending Physician in the Division of Hematology/Oncology at Massachusetts General Hospital (MGH). He attended Colby College for undergraduate studies and then matriculated to the University of Connecticut Medical School, graduating in 2001. He first trained in Internal Medicine at Mount Auburn Hospital in Cambridge, MA and then at Beth Israel Deaconess Medical Center (BIDMC) in Hematology/Oncology. He joined the MGH Cancer Center in 2011 and serves as a member of the Center for Melanoma and the Teermer Center for Targeted Therapy. He is an Assistant Professor at Harvard Medical School.
Dr. Donald Lawrence
Donald Lawrence, MD is the clinical director of the Center for Melanoma at Massachusetts General Hospital and has been in practice for more than 25 years. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and completed his medical training at Beth Israel Deaconess Medical Center and Tufts Medical Center. Dr. Lawrence is a lecturer in medicine at Harvard Medical School and leads numerous clinical trials with a research interest in immunotherapy. Dr. Lawrence is also on the medical advisory board at IMPACT melanoma.